Technical Data Sheet
IGF-1 LR3
Also Known As: Long-Arg3 IGF-I, Insulin-like Growth Factor 1 LR3, IGF1 LR3, IGF-1 LR3, Long R3 IGF-1, Long R3 insulin-like growth factor, IGF LR3, LR3 IGF-1, Des(1-3)-IGF-1 long analog, IGF1-LR3 recombinant, Anabolic growth factor peptide, Muscle growth factor IGF, Somatomedin C analog, Insulin-like Growth Factor 1 Long Arg3, IGF1-LR3
Scan To View Profile
| Evidence Tier | Research Compound |
|---|---|
| Category | Muscle Growth & Performance |
| Class | Long-acting recombinant IGF-1 analog (Arg3 substitution, 13 N-terminal extension) |
| Molecular Target | IGF-1 receptor (IGF1R); PI3K/Akt/mTOR signaling; satellite cell proliferation; reduced IGFBP binding = extended half-life |
| Sequence | 83-aa analog (Arg3 + N-terminal extension) |
| Molecular Weight | ~9.1 kDa |
| CAS | 946870-92-4 |
| Parent | Insulin-like growth factor 1 |
| Mechanism | It binds to receptors that trigger massive cell division and growth in muscle tissue. The LR3 modification prevents it from being deactivated by blood proteins, extending its active life from minutes to over 20 hours. |
| Studied For | Muscle growth / hypertrophy, Anabolic research, GH axis signaling, Lean mass increase, Satellite cell activation, Muscle protein synthesis, Anti-catabolic research, Fat loss via anabolic signaling, Bone density support, Tendon collagen synthesis, Nerve growth and repair, Cartilage repair, Glucose uptake / insulin sensitivity, Cell proliferation research, GH-independent anabolic pathway, Recovery and repair acceleration, Body recomposition research, muscle hyperplasia, site enhancement, anabolic, muscle growth, recovery, anti-aging |
| Administration Route | Injection Only |
| Form | lyophilized |
| Diluent | dilute acetic acid or sterile/bacteriostatic water per supplier |
| Storage Temperature | -4°F, dark |
| Light Sensitive | Yes |
| Freeze / Thaw | avoid |
| Reconstituted Shelf Life | 14 Days |
| Handling Notes | Aliquot and freeze for longer storage. |
| Regulatory | Not FDA-approved for humans (distinct from approved mecasermin); research/cell-culture reagent; WADA S2. |
| Sources |